Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
111,111,111
-
Number of holders
-
55
-
Total 13F shares, excl. options
-
13,609,704
-
Shares change
-
+2,300,693
-
Total reported value, excl. options
-
$196,872,145
-
Value change
-
+$32,309,931
-
Put/Call ratio
-
55.33%
-
Number of buys
-
35
-
Number of sells
-
-21
-
Price
-
$14.48
Significant Holders of NovoCure Ltd - Common Stock (NVCR) as of Q1 2016
72 filings reported holding NVCR - NovoCure Ltd - Common Stock as of Q1 2016.
NovoCure Ltd - Common Stock (NVCR) has 55 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13,609,704 shares
of 111,111,111 outstanding shares and own 12.25% of the company stock.
Largest 10 shareholders include FMR LLC (5,525,221 shares), PRICE T ROWE ASSOCIATES INC /MD/ (2,588,465 shares), StepStone Group LP (1,815,479 shares), HIGHLINE CAPITAL MANAGEMENT, L.P. (1,533,679 shares), MORGAN STANLEY (264,385 shares), DEUTSCHE BANK AG\ (256,687 shares), Rock Springs Capital Management LP (214,316 shares), ALKEON CAPITAL MANAGEMENT LLC (196,609 shares), BlackRock Fund Advisors (196,485 shares), and STATE STREET CORP (122,539 shares).
This table shows the top 55 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.